Jazz Pharmaceuticals plc (NASDAQ: JAZZ): Analyst View Points To Future Growth
Jazz Pharmaceuticals plc (JAZZ) concluded trading on Wednesday at a closing price of $108.64, with 4.22 million shares of worth about $458.79 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.26% during that period and on September 04, 2024 the price saw a […]
